VMP 36093911000001108

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Desferrioxamine 500mg powder for solution for injection vials
BNF code 0901030P0AAAAAA
Virtual Therapeutic Moiety Desferrioxamine
Date identifier became valid 31 Oct 2018
Previous product identifier 329478002
Abbreviated name Desferrioxamine 500mg inj vials
Basis of preferred name BAN - British Approved Name
Date of name applicability 18 May 2004
Previous name Desferrioxamine 500mg injection vials
Basis of previous name BAN - British Approved Name
Reason for name change Other
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units vial
Unit dose unit of measure vial
Virtual Product Ingredient
Ingredient Desferrioxamine mesilate
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 500.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route solutioninfusion.intraperitoneal
Ontology Drug Form & Route
Form & Route solutioninfusion.subcutaneous
Ontology Drug Form & Route
Form & Route solutioninfusion.intravenous
Ontology Drug Form & Route
Form & Route solutioninjection.intramuscular
Dose Form
Formulation Powder for solution for injection
Drug Route
Route Intramuscular
Drug Route
Route Subcutaneous
Drug Route
Route Intravenous
Drug Route
Route Intraperitoneal
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Desferal 500mg powder for solution for injection vials (Novartis Pharmaceuticals UK Ltd)
Desferal 500mg powder for solution for injection vials (Sigma Pharmaceuticals Plc)
Desferrioxamine 500mg powder for solution for injection vials (Kent Pharma (UK) Ltd)
Virtual Medicinal Product Packs
Desferrioxamine 500mg powder for solution for injection vials 10 vial

dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.

Feedback